Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Archives of Medical Research
|
February 4, 2012
Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9
Alexander Constantinides, Paul J W H Kappelle, Gilles Lambert, et al.
European Journal of Clinical Investigation
|
September 11, 2012
Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium
Alexander Constantinides, Michiel N Kerstens, Bert D Dikkeschei, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 22, 2011
Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile
Robin P F Dullaart, Alexander Constantinides, Frank G Perton, et al.
European Journal of Internal Medicine
|
August 21, 2012
Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity
Alexander Constantinides, Rindert de Vries, Jeroen J J van Leeuwen, et al.
European Journal of Clinical Investigation
|
February 2, 2011
Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes
Alexander Constantinides, L Joost van Pelt, Jeroen J J van Leeuwen, et al.
Translational Oncology
|
July 2, 2025
Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade
Alexander Constantinides, Nico Lansu, Peter Mosen, et al.
The Journal of Pathology. Clinical Research
|
February 26, 2021
Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid
Iris Van't Erve, Koen P Rovers, Alexander Constantinides, et al.
Frontiers in Oncology
|
September 23, 2022
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
Niek A Peters, Alexander Constantinides, Inge Ubink, et al.
British Journal of Cancer
|
February 23, 2022
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
Jamila Laoukili, Alexander Constantinides, Emma C E Wassenaar, et al.
BMJ Open
|
July 29, 2019
Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)
Koen P Rovers, Robin J Lurvink, Emma Ce Wassenaar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Archives of Medical Research
|
February 4, 2012
Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9
Alexander Constantinides, Paul J W H Kappelle, Gilles Lambert, et al.
European Journal of Clinical Investigation
|
September 11, 2012
Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium
Alexander Constantinides, Michiel N Kerstens, Bert D Dikkeschei, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 22, 2011
Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile
Robin P F Dullaart, Alexander Constantinides, Frank G Perton, et al.
European Journal of Internal Medicine
|
August 21, 2012
Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity
Alexander Constantinides, Rindert de Vries, Jeroen J J van Leeuwen, et al.
European Journal of Clinical Investigation
|
February 2, 2011
Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes
Alexander Constantinides, L Joost van Pelt, Jeroen J J van Leeuwen, et al.
Translational Oncology
|
July 2, 2025
Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade
Alexander Constantinides, Nico Lansu, Peter Mosen, et al.
The Journal of Pathology. Clinical Research
|
February 26, 2021
Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid
Iris Van't Erve, Koen P Rovers, Alexander Constantinides, et al.
Frontiers in Oncology
|
September 23, 2022
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
Niek A Peters, Alexander Constantinides, Inge Ubink, et al.
British Journal of Cancer
|
February 23, 2022
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
Jamila Laoukili, Alexander Constantinides, Emma C E Wassenaar, et al.
BMJ Open
|
July 29, 2019
Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)
Koen P Rovers, Robin J Lurvink, Emma Ce Wassenaar, et al.
Page
of 2